Impact of Programmed Death Ligand 1 Expression in Advanced Non-Small-Cell Lung Cancer Patients, Treated by Chemotherapy (GFPC 06-2015 Study).
Jean-Bernard AuliacFlorian GuisierAcya BizieuxPascal AssoulineMarie BernardiniRégine LamyGrégoire JusteauGeraldine FrançoisDiane DamotteChristos ChouaidPublished in: OncoTargets and therapy (2020)
According to the results of this prospective, multicenter study, neither TC nor IC PD-L1 expression appears to be prognostic for chemotherapy-managed advanced NSCLC patients.
Keyphrases
- advanced non small cell lung cancer
- end stage renal disease
- epidermal growth factor receptor
- chronic kidney disease
- ejection fraction
- newly diagnosed
- small cell lung cancer
- poor prognosis
- locally advanced
- prognostic factors
- peritoneal dialysis
- squamous cell carcinoma
- radiation therapy
- binding protein
- chemotherapy induced